You have Guest access.
Log In
Published in partnership with the
European Association for the Study of Diabetes
Volume 1 / 1965 - Volume 55 / 2012
Remove criteria to expand these results
Add criteria from below to refine these results
List of Refereees
LIST OF REFEREES
Online First™, 1 February 2012
Article
Age-related islet autoantibody incidence in offspring of patients with type 1 diabetes
A.-G. Ziegler, E. Bonifacio and the BABYDIAB-BABYDIET Study Group
Online First™, 31 January 2012
Resting heart rate and the risk of death and cardiovascular complications in patients with type 2 diabetes mellitus
G. S. Hillis, M. Woodward, A. Rodgers, C. K. Chow and Q. Li, et al.
Online First™, 28 January 2012
Steroid-induced insulin resistance and impaired glucose tolerance are both associated with a progressive decline of incretin effect in first-degree relatives of patients with type 2 diabetes
D. H. Jensen, K. Aaboe, J. E. Henriksen, A. Vølund and J. J. Holst, et al.
The Diabetes Excess Weight Loss (DEWL) Trial: a randomised controlled trial of high-protein versus high-carbohydrate diets over 2 years in type 2 diabetes
J. D. Krebs, C. R. Elley, A. Parry-Strong, H. Lunt and P. L. Drury, et al.
Pancreatic diabetes manifests when beta cell area declines by approximately 65% in humans
J. J. Meier, T. G. K. Breuer, R. C. Bonadonna, A. Tannapfel and W. Uhl, et al.
Online First™, 27 January 2012
Commentary
Complement C3: an emerging risk factor in cardiometabolic disease
E. Hertle, M. M. J. van Greevenbroek and C. D. A. Stehouwer
Online First™, 26 January 2012
Contractile activity of human skeletal muscle cells prevents insulin resistance by inhibiting pro-inflammatory signalling pathways
S. Lambernd, A. Taube, A. Schober, B. Platzbecker and S. W. Görgens, et al.
The proteomic signature of insulin-resistant human skeletal muscle reveals increased glycolytic and decreased mitochondrial enzymes
J. Giebelstein, G. Poschmann, K. Højlund, W. Schechinger and J. W. Dietrich, et al.
Systematic review
Impact of current treatments on liver disease, glucose metabolism and cardiovascular risk in non-alcoholic fatty liver disease (NAFLD): a systematic review and meta-analysis of randomised trials
G. Musso, M. Cassader, F. Rosina and R. Gambino
Frequently asked questions General info on journals and books Send us your feedback Impressum Contact us
© Springer, Part of Springer Science+Business Media Privacy, Disclaimer, Terms & Conditions, and Copyright Info